Operator: Thank you for standing by, and welcome to MaxCyte s Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
ROCKVILLE, Md., March 27, 2023 MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization. | March 27, 2023
/PRNewswire/ NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal.
AavantiBio Deepens AAV Manufacturing Capabilities with Key Hires to Support Strategic Growth yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.